Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Lobna R. Ezz Elarab"'
Autor:
Meteb Al-Foheidi, Fatina M. Al Tahan, Ahmed Saadeddin, Hannah Chung, Banu Arun, Hany Abdel-Aziz, Mohamed Sabry, Manal Abdel-Wahab, Nivine Gado, Marwan Ghosn, Armando E. Giuliano, Azza Nasr, Hagar Elghazawy, Khaled Abdel Karim, Mona Frolova, Benjamin O. Anderson, Nermean Bahie Eldin, Heba M. El-Zawahry, Mohamed A Shehata, Lobna R. Ezz Elarab, Hussein Maki, Adel T. Aref, Rasha Kamal, Nivine Chalabi, Cheng Har Yip, Hesham Elghazaly, Jessica W.T. Leung, Charles M. Balch, Gilda Cardenosa
Publikováno v:
International journal of cancerREFERENCES. 149(3)
In low-middle income countries (LMICs) and the Middle East and North Africa (MENA) region, there is an unmet need to establish and improve breast cancer (BC) awareness, early diagnosis and risk reduction programs. During the 12th Breast, Gynecologica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f5fa23b3c13ec75c35ffa7e10f1405c
https://pubmed.ncbi.nlm.nih.gov/33559295
https://pubmed.ncbi.nlm.nih.gov/33559295
Autor:
Mohamed S. Elashry, Nicolas Mottet, Mai Ezz El Din, Mohamed A Abo El-Fotouh, Khalid Abdelkarim, Claude C. Abbou, A. Emara, Samir Shehata, Akram Assem, Mack Roach, Hesham Tawfik, Jorge A. Garcia, Lobna R. Ezz Elarab, Shouki Bazarbashi, Axel S. Merseburger, Ola Khorshid, Hesham Elwakil, Abbass Omar, Hesham Elghazaly, Tarek Osman, Ahmed M. Selim, Stéphane Oudard
Publikováno v:
World journal of urology. 39(5)
Advancements in the diagnosis and treatment of prostate cancer (PC) have rapidly progressed through the past years. Various factors should be taken into account while treating individual patients to ensure optimal and careful decision making. The pur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce7b7b15fcf13f7760853f23724c527b
https://pubmed.ncbi.nlm.nih.gov/32643031
https://pubmed.ncbi.nlm.nih.gov/32643031
Publikováno v:
Journal of the Egyptian National Cancer Institute. 24(1):15-22
Background Anticancer chemotherapy is thought to be effective by means of direct cytotoxicity on tumor cells. Alternative mechanisms of efficacy have been ascribed to several common anticancer agents; including cyclophosphamide (CTX) and capecitabine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73ed06a8f1da84e07df485af30935cde
Publikováno v:
The Chinese-German Journal of Clinical Oncology. 9:718-723
Hepatocellular carcinoma (HCC) is the sixth most common cancer in the world and the third leading cause of cancer related death globally. Parentral treatment of Egyptian patients of bilharziasis contributed to the high incidence of viral hepatitis, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dca5af76a9d922fdd2ff64548e9ad068
https://doi.org/10.1007/s10330-010-0698-y
https://doi.org/10.1007/s10330-010-0698-y
Publikováno v:
The Chinese-German Journal of Clinical Oncology. 9:700-707
The triple negative (TN) metastatic breast cancer (MBC) patients are known to have worse prognosis, shorter progressive free survival (PFS), and overall survival (OS), that mandates using aggressive chemotherapy regimens. This phase II study aimed at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27044518b6daf8aca8a9d38b63bf411e
https://doi.org/10.1007/s10330-010-0699-x
https://doi.org/10.1007/s10330-010-0699-x
Publikováno v:
The Chinese-German Journal of Clinical Oncology. 9:574-578
Objective Postmenopausal women with breast cancer are at increased risk of bone loss because of age related estrogen deficiency face which accelerated with the use of aromatase inhibitors (AIs). We aimed to study the effect on bone mineral density (B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf2760b1680dc180d17043f445df99f0
https://doi.org/10.1007/s10330-010-0676-4
https://doi.org/10.1007/s10330-010-0676-4
Publikováno v:
The Chinese-German Journal of Clinical Oncology. 9:569-573
Objective The aim of our study was to evaluate the response and tolerability to treatment when using gemcitabine-cisplatin combination (GC), followed by maintenance therapy of oral etoposide for non-progressive patients in trial to improve progressio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36d9e70253ba3c6f9ca4d1be824fe9a9
https://doi.org/10.1007/s10330-010-0675-5
https://doi.org/10.1007/s10330-010-0675-5
Publikováno v:
Clinical biochemistry. 41(13)
Objective Combining information derived from cellular biomarkers as telomerase and genes encoding cyclin dependent kinase inhibitors (p16INK4a and p15INK4b) is needed to facilitate the stratification of individual patients within the conventional cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed20ed9ee2b3f05f7b91da567b6a3904
https://pubmed.ncbi.nlm.nih.gov/18602381
https://pubmed.ncbi.nlm.nih.gov/18602381